JW LifescienceJW생명과학
234080 · KOSPI · ₩234080 · JW생명과학
₩10,440▲ ₩20 (0.19%)End-of-day · Oct 27, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 28.2% | 28.0% | 25.8% | 25.3% | 25.5% | 28.9% |
| Operating margin | 13.1% | 12.9% | 16.1% | 14.9% | 14.3% | 16.7% |
| Net margin | 12.7% | 11.1% | 19.8% | 13.6% | 7.9% | 7.2% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | −1.6% | +15.9% | +7.5% | +9.5% | +11.3% | — |
| Operating income growth | +0.3% | −7.3% | +16.2% | +13.9% | −4.7% | — |
| Net income growth | +12.3% | −35.0% | +56.3% | +88.1% | +22.9% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 14.4% | 13.6% | 24.4% | 18.8% | 11.0% | 9.3% |
| Return on assets | 8.2% | 8.9% | 15.1% | 11.1% | 6.3% | 5.6% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 34.8% | 44.3% | 62.3% | 60.5% | 80.2% | 67.3% |
| Net debt to equity | 9.5% | 18.4% | 16.2% | 6.5% | 45.0% | 31.6% |
| Current ratio | 125.2% | 104.6% | 131.8% | 114.4% | 131.2% | 76.8% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: JW Lifescience / JW생명과학 / 234080 / KRX:234080
Source: KRX statistical information